Dengue fever remains one of the most significant viral infections worldwide, particularly in tropical and subtropical regions. Every year, millions of people are affected, with a substantial number requiring hospitalization due to its potentially severe complications. In this blog, we’ll take a closer look at dengue fever, its symptoms, how it spreads, and the promising new vaccine—Qdenga—that’s making a difference in the fight against this debilitating disease.
1. What is Dengue Fever?
Dengue fever is a viral infection caused by the dengue virus (DENV), which is transmitted to humans primarily through the bite of infected Aedes mosquitoes. The disease is most commonly found in areas of Southeast Asia, the Pacific Islands, Africa, and Latin America, but with increasing global travel, cases are reported in new regions each year.
Once a person is infected, the virus incubates in the body for 4-10 days before symptoms appear. Dengue fever can range from mild to severe, with severe cases leading to hemorrhagic fever or dengue shock syndrome, both of which can be fatal without prompt medical care.
2. Symptoms of Dengue Fever
The symptoms of dengue fever often resemble those of other viral illnesses, making diagnosis challenging without proper testing. However, the hallmark symptoms of dengue include:
- High fever (often as high as 104°F or 40°C)
- Severe headache, typically in the forehead area
- Pain behind the eyes
- Joint and muscle pain, often severe enough to lead to the term “breakbone fever”
- Rash that may appear a few days after fever onset
- Nausea and vomiting
- Fatigue and weakness that can last for weeks
In severe cases, patients may experience bleeding, low blood pressure, and organ failure, which require immediate medical attention.
3. How is Dengue Spread?
Dengue is primarily transmitted through the bite of an infected Aedes mosquito, particularly Aedes aegypti and Aedes albopictus. These mosquitoes are most active during the day, especially early in the morning and late afternoon.
The mosquitoes become infected when they bite a person already infected with the dengue virus. After the virus incubates inside the mosquito, it can be transmitted to humans when the mosquito bites again.
It’s important to note that dengue is not transmitted directly from person to person. The only way to contract the virus is through mosquito bites.
4. Preventing Dengue Fever
Prevention of dengue fever revolves primarily around controlling mosquito populations and reducing exposure to mosquitoes. Here are key prevention strategies:
- Eliminate mosquito breeding sites: Mosquitoes lay their eggs in stagnant water. Regularly empty and clean containers like flower pots, bird baths, and water storage tanks.
- Use insect repellent: DEET-based repellents are effective in preventing mosquito bites.
- Wear protective clothing: Long sleeves, pants, and mosquito nets can provide additional protection.
- Install window and door screens to prevent mosquitoes from entering homes.
Dengue fever doesn’t have a specific treatment. Prevention is therefore really important.
5. The Role of Qdenga: A Breakthrough in Dengue Vaccination
One of the most exciting advancements in dengue control is the development of a vaccine called Qdenga. Unlike previous dengue vaccines, which were limited in their efficacy and safety, Qdenga has shown significant promise in protecting individuals against all four serotypes of the dengue virus. This vaccine is available at Intercare.
What makes Qdenga different?
- Broad protection: Qdenga is designed to offer protection against all four strains (serotypes) of the dengue virus, which is essential because the virus can evolve into multiple forms.
- Improved safety: Previous vaccines showed reduced efficacy in individuals who had not been previously infected with dengue. Qdenga, however, has shown more consistent safety and effectiveness across diverse populations.
- Global impact: With millions of cases worldwide, Qdenga offers a potential global solution to one of the most pressing public health challenges. The vaccine is expected to reduce both the incidence of dengue and its severe complications.
Who Should Get Qdenga?
Qdenga is recommended for individuals living in endemic areas who are aged 4-60 years, and it is typically given as a two-dose series. The vaccine is suitable for people regardless of whether they’ve been previously infected with the dengue virus. However, like all vaccines, it’s important to consult with a healthcare professional to determine the best course of action based on individual health needs.
6. Looking to the Future: Ending the Dengue Crisis
While Qdenga represents a major milestone in the battle against dengue fever, it is not a stand-alone solution. Continued efforts to reduce mosquito breeding sites, improve public awareness, and ensure equitable access to vaccines are essential for making a long-term impact.
In conclusion, dengue fever is a disease that continues to pose a serious threat to public health, but with advancements like Qdenga, we are moving closer to reducing its global burden. By adopting preventive measures and supporting vaccination efforts, we can work towards a future where dengue no longer causes unnecessary illness and death.
Stay informed, stay safe, and consider discussing with your healthcare provider whether Qdenga or other preventive measures might be right for you.
